BMY Operating Cash Flow (Statement)

Bristol Myers Squibb · Operating Cash Flow (Statement)

BMY logo

BMY Operating Cash Flow (Statement)

Latest reported$12.78B
BMY TTM Cash from Operations ($1.75B → $12.78B)
High-resolution chart · PNG

BMY operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bristol Myers Squibb Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
12,782,000,000
13,306,000,000
14,156,000,000
16,621,000,000
15,901,000,000
14,310,000,000
15,190,000,000
15,003,000,000
14,163,000,000
13,724,000,000
13,860,000,000
12,914,000,000
11,850,000,000
12,224,000,000
13,066,000,000
13,817,000,000
15,396,000,000
16,195,000,000
16,207,000,000
15,820,000,000
12,821,000,000
14,254,000,000
14,367,000,000
12,735,000,000
13,024,000,000
10,614,000,000
8,067,000,000
8,458,000,000
7,181,000,000
6,155,000,000
5,940,000,000
4,628,000,000
5,062,000,000
5,589,000,000
5,275,000,000
5,586,000,000
5,277,000,000
4,132,000,000
3,043,000,000
2,226,000,000
1,346,000,000
978,000,000
1,832,000,000
1,793,000,000
2,172,000,000
3,157,000,000
3,148,000,000
3,986,000,000
4,136,000,000
4,590,000,000
3,545,000,000
2,971,000,000
6,502,000,000
6,126,000,000
6,941,000,000
7,673,000,000
4,787,000,000
4,746,000,000
4,840,000,000
4,867,000,000
4,552,000,000
4,508,000,000
4,491,000,000
4,240,000,000
4,330,000,000
4,077,000,000
4,065,000,000
3,087,000,000
3,066,000,000
3,384,000,000
3,707,000,000
3,971,000,000
3,216,000,000
3,163,000,000
3,153,000,000
2,734,000,000
2,981,000,000
2,765,000,000
2,083,000,000
2,197,000,000
2,013,000,000
1,164,000,000
1,864,000,000
2,222,000,000
2,043,000,000
2,878,000,000
3,176,000,000
3,745,000,000
4,115,000,000
4,434,000,000
3,513,000,000
2,954,000,000
2,940,000,000
2,196,000,000
950,000,000
2,223,000,000
2,339,000,000
3,447,000,000
5,402,000,000
5,256,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.